Intraoperative Methadone Dosing for Primary Analgesia
For adult patients undergoing surgery, administer intravenous methadone at 0.2 mg/kg ideal body weight as a single dose at the start of surgery when using it as the primary intraoperative analgesic.
Adult Dosing Recommendations
The evidence strongly supports 0.2 mg/kg ideal body weight as the optimal dose for most surgical procedures 1. This dose has been validated in complex spine surgery, where it significantly reduced postoperative opioid consumption (median 4.56 mg vs 9.90 mg hydromorphone on postoperative day 1, P<0.001), decreased pain scores at 21 of 27 assessments, and improved patient satisfaction 1.
Dose Adjustments by Surgical Context:
- Complex spine and major surgery: 0.2 mg/kg ideal body weight 1
- Cardiac surgery: 0.3 mg/kg ideal body weight has been studied 2
- Next-day discharge outpatient surgery: 0.25 mg/kg ideal body weight (median 14 mg) was identified as the most effective and well-tolerated dose 3
- Moderate-to-severely painful surgery: 0.2 mg/kg demonstrated efficacy with median cumulative morphine consumption of 19 mg vs 35 mg over 72 hours (P<0.05) 4
Timing is critical: Administer methadone at anesthesia induction or the start of surgery, not at surgical closure. This allows adequate time for the drug to reach therapeutic levels given its slower onset compared to short-acting opioids 1, 3.
Pediatric Dosing Recommendations
For children aged 3-17 years undergoing tonsillectomy, 0.15 mg/kg age-ideal body weight is the recommended dose 5. This dose resulted in:
- Median 7-day opioid use of 0.5 oral morphine equivalents/kg vs 1.5 in controls (P=0.023)
- Postanesthesia care unit opioid use of 0.0 vs 0.15 oral morphine equivalents/kg (P=0.021)
- No serious opioid-related adverse events
The lower dose of 0.1 mg/kg in pediatrics showed benefit but was less effective than 0.15 mg/kg 5.
Clinical Considerations
Pharmacokinetic properties: Methadone's elimination half-life is 8-59 hours (substantially longer than morphine's 1-5 hours), but its analgesic duration is typically 4-8 hours with single dosing 6. Peak respiratory depressant effects occur later and persist longer than peak analgesic effects 6.
Anesthetic management: Methadone can serve as the sole intraoperative opioid when combined with propofol or volatile anesthetics 3. Additional short-acting opioids (fentanyl, hydromorphone) may be used as needed for breakthrough requirements, but total intraoperative opioid consumption is typically reduced compared to conventional short-acting opioid-only approaches 3, 4.
Postoperative benefits extend beyond immediate period: In spine surgery, analgesic benefits persisted through the first 3 months postoperatively, with patients reporting less frequent chronic pain (median score 0 vs 3 [daily] at 3 months, P=0.004) 2. For cardiac surgery, benefits were observed during the first month when pain intensity was greatest 2.
Safety Profile
Common pitfall: Do not confuse intraoperative analgesic dosing with addiction treatment dosing. The FDA label dosing for opioid use disorder (20-40 mg daily for maintenance) 6 is not applicable to acute perioperative pain management.
Monitoring requirements: Standard postoperative opioid monitoring is appropriate. The studies reviewed showed no increase in opioid-related adverse events compared to short-acting opioids 1, 3, 5. However, be aware that methadone's respiratory depressant effects may outlast its analgesic effects 6.
Contraindications and cautions: The available guidelines focus on pediatric withdrawal management and opioid use disorder 7, not intraoperative analgesia. Standard opioid precautions apply, with particular attention to patients with reduced opioid tolerance or those who have not taken opioids for more than 5 days 6.